Dr James E Bennett
School of Public Health
Tel: +44 (0)20 7594 3371
Dr James E Bennett
Dr James Bennett gained a Bsc in Applied Mathematics at Warwick University before moving to Imperial College statistics department to study for his PhD under Professor Jon Wakefield. The PhD was sponsored by Glaxo Plc and was entitled "Bayesian Analysis of Population Pharmacokinetic Models".
Following the completion of his PhD he has held a wide variety of post-doctoral research contracts predominantly in the Department of Epidemiology and Biostatistics at St Mary's Medical School, Imperial College.
Research Interests: environmental epidemiology; small area health statistics; bayesian hierarchical models; exposure modelling.
1996 – Current Research Fellow, MRC-HPA Centre for Environment and Health, Department of Epidemiology and Biostatistics, School of Public Health; Imperial College, London, UK.
2011 – International trends in cardio-vascular disease mortality.
2010 – 2011 COSMOS, Cohort study of mobile phone use and health. (UK Mobile Telecommunications Health Research – MTHR)
2007 – 2010 HiWATE, Modelling of Chlorination Disinfection By-Products in Drinking Water and relation to birth outcomes. (EU)
2006 – 2007 Mobile phone Mast bases stations exposure and childhood cancers. (MTHR)
2005 – 2006 OPUS, Combining data from different sources and aggregation levels in the area of transport and pollution modelling. (EU)
2005 Does biological fertility influence sex ratio at birth? (MRC)
2002 – 2003 Modelling of water mediated trihalomethane exposure across Great Britain. (Water industry and The Department of the Environment)
2001 –2002 Flexible dose response models in the Life Span Study cohort of atomic bomb survivors. (EU)
1999 – 2002 Spatial mapping of diabetes incidence, disease management measures and clinical outcomes. (British Diabetic Association and NICE, DoH)
1999 Analysis of Hospital Episode Statistics for the Bristol Royal Infirmary Inquiry. (DoH)
1999 – 2000 Physiologically based modelling of the absorption and elimination of aspartame by-products. (DoH/FSA)
1998 Small area modelling of tuberculosis in UK cities, competing effects of ethnicity and deprivation. (Nuffield Trust)
1997 – 1998 Population pharmacokinetic and pharmacodynamic modelling. (Realising Our Potential Award)
1996 – 1997 Small area mapping of disease risk and modelling of explanatory factors. (North Thames RHA)
1995 – 1996 Research Associate; Department of Statistics; Imperial College; London; UK
1995 – 1996 Jump Markov chain Monte Carlo techniques in covariate modelling. (EPSRC)
1995, 1996 Population pharmacokinetic modelling of bismuth and the reanalysis of bismuth toxicity data. (Glaxo Wellcome)